Cargando…

Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer

Colorectal carcinoma (CRC) is one of the most common malignancies with a dismal 5-year survival rate. Our recent study indicated that Rab1A expression was closely related to GLI1 expression. A previous study shows that aberrant overexpression of GLI1 promotes colorectal cancer metastasis via FoxM1 o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Menglin, Shao, Xinyu, Li, Haoran, Zhang, Zhengrong, Zhou, Chunli, Cheng, Zhengwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678875/ https://www.ncbi.nlm.nih.gov/pubmed/33214609 http://dx.doi.org/10.1038/s41598-020-77182-z

Ejemplares similares

Prognosis value and positive association of Rab1A/IL4Rα aberrant expression in gastric cancer
por: Li, Haoran, et al.
Publicado: (2023)

ENO1 Acts as a Prognostic Biomarker Candidate and Promotes Tumor Growth and Migration Ability Through the Regulation of Rab1A in Colorectal Cancer
por: Cheng, Zhengwu, et al.
Publicado: (2019)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis
por: Yao, Yizhou, et al.
Publicado: (2018)

Pooled analysis of prognostic value and clinical significance of Rab1A expression in human solid tumors
por: Shao, Xinyu, et al.
Publicado: (2019)

Expression analysis and implication of Rab1A in gastrointestinal relevant tumor
por: Xu, Menglin, et al.
Publicado: (2019)

Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer
por: Cheng, Zhengwu, et al.
Publicado: (2019)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas
por: Zeng, Wen‐Jing, et al.
Publicado: (2020)

FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
por: Zhang, Chunli, et al.
Publicado: (2018)

FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion
por: Zheng, Yun, et al.
Publicado: (2015)

AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1
por: Xu, Menglin, et al.
Publicado: (2020)

FoxM1 Is a General Target for Proteasome Inhibitors
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Deregulation of FoxM1b leads to tumour metastasis
por: Park, Hyun Jung, et al.
Publicado: (2011)

FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter
por: Huang, Chao, et al.
Publicado: (2019)

FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition
por: Fei, Bao-Ying, et al.
Publicado: (2017)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

Analysis of survivin, XIAP and FoxM1 as potential chemoresistance factors in breast cancer cells
por: Moraes, Gabriela N, et al.
Publicado: (2013)

Novel functions of FoxM1: from molecular mechanisms to cancer therapy
por: Alvarez-Fernández, Mónica, et al.
Publicado: (2013)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

FoxM1 is a promising candidate target in the treatment of breast cancer
por: Lu, Xiao-Feng, et al.
Publicado: (2017)

An order-to-disorder structural switch activates the FoxM1 transcription factor
por: Marceau, Aimee H, et al.
Publicado: (2019)

FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis
por: Qin, Qin, et al.
Publicado: (2023)

TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
por: Zheng, Shuier, et al.
Publicado: (2020)

Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
por: Pan, Huafeng, et al.
Publicado: (2018)

FoxM1 Promotes Glioma Cells Progression by Up-Regulating Anxa1 Expression
por: Cheng, Shi-Xiang, et al.
Publicado: (2013)

FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
por: Yu, Chun-Peng, et al.
Publicado: (2017)

A Cdh1–FoxM1–Apc axis controls muscle development and regeneration
por: Chen, Zhe, et al.
Publicado: (2020)

Correction: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
por: Zheng, Shuier, et al.
Publicado: (2022)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
por: Littler, D. R., et al.
Publicado: (2010)

Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation
por: Xiang, D, et al.
Publicado: (2014)

CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction
por: Jang, Woo Dae, et al.
Publicado: (2022)

Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
por: Wang, Liang, et al.
Publicado: (2019)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
por: Ahmed, Maqbool, et al.
Publicado: (2015)

Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1
por: Qian, Jianxin, et al.
Publicado: (2013)

FoxM1 Directs STAT3 Expression Essential for Human Endometrial Stromal Decidualization
por: Jiang, Yaling, et al.
Publicado: (2015)

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
por: Zhang, Zhenfeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9a72dadbf06ol9pvgv93ueisbr